ProShares Ultra Bitcoin ETF vs Boston Scientific Corporation — how do they compare? ProShares Ultra Bitcoin ETF trades at $9.36, while Boston Scientific Corporation trades at $51.07 (market cap $74.19B). The key difference: Boston Scientific Corporation is trading nearer its 52-week high, ProShares Ultra Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| BITU | BSX | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $64.41 | $108.14 |
52-Week Low | $8.12 | $42.63 |
Market Cap | — | $74.19B |
Enterprise Value | — | $86.27B |
Trailing returns across standard periods
Latest headlines on both assets
BITU is a leveraged ETF that seeks to provide two times (2x) the daily performance of Bitcoin. It is designed for sophisticated investors looking for magnified exposure to Bitcoin’s daily price movements.
Read more on BITU →Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →